Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Prosit: proteome-wide prediction of peptide tandem mass spectra by deep learning.

Gessulat S, Schmidt T, Zolg DP, Samaras P, Schnatbaum K, Zerweck J, Knaute T, Rechenberger J, Delanghe B, Huhmer A, Reimer U, Ehrlich HC, Aiche S, Kuster B, Wilhelm M.

Nat Methods. 2019 Jun;16(6):509-518. doi: 10.1038/s41592-019-0426-7. Epub 2019 May 27.

PMID:
31133760
2.

A deep proteome and transcriptome abundance atlas of 29 healthy human tissues.

Wang D, Eraslan B, Wieland T, Hallström B, Hopf T, Zolg DP, Zecha J, Asplund A, Li LH, Meng C, Frejno M, Schmidt T, Schnatbaum K, Wilhelm M, Ponten F, Uhlen M, Gagneur J, Hahne H, Kuster B.

Mol Syst Biol. 2019 Feb 18;15(2):e8503. doi: 10.15252/msb.20188503.

3.

ProteomeTools: Systematic Characterization of 21 Post-translational Protein Modifications by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) Using Synthetic Peptides.

Zolg DP, Wilhelm M, Schmidt T, Médard G, Zerweck J, Knaute T, Wenschuh H, Reimer U, Schnatbaum K, Kuster B.

Mol Cell Proteomics. 2018 Sep;17(9):1850-1863. doi: 10.1074/mcp.TIR118.000783. Epub 2018 May 29.

4.

Mining the Human Tissue Proteome for Protein Citrullination.

Lee CY, Wang D, Wilhelm M, Zolg DP, Schmidt T, Schnatbaum K, Reimer U, Pontén F, Uhlén M, Hahne H, Kuster B.

Mol Cell Proteomics. 2018 Jul;17(7):1378-1391. doi: 10.1074/mcp.RA118.000696. Epub 2018 Apr 2.

5.

PROCAL: A Set of 40 Peptide Standards for Retention Time Indexing, Column Performance Monitoring, and Collision Energy Calibration.

Zolg DP, Wilhelm M, Yu P, Knaute T, Zerweck J, Wenschuh H, Reimer U, Schnatbaum K, Kuster B.

Proteomics. 2017 Nov;17(21). doi: 10.1002/pmic.201700263. Epub 2017 Oct 24.

PMID:
28872757
6.

Building ProteomeTools based on a complete synthetic human proteome.

Zolg DP, Wilhelm M, Schnatbaum K, Zerweck J, Knaute T, Delanghe B, Bailey DJ, Gessulat S, Ehrlich HC, Weininger M, Yu P, Schlegl J, Kramer K, Schmidt T, Kusebauch U, Deutsch EW, Aebersold R, Moritz RL, Wenschuh H, Moehring T, Aiche S, Huhmer A, Reimer U, Kuster B.

Nat Methods. 2017 Mar;14(3):259-262. doi: 10.1038/nmeth.4153. Epub 2017 Jan 30.

7.

Mass-spectrometry-based draft of the human proteome.

Wilhelm M, Schlegl J, Hahne H, Gholami AM, Lieberenz M, Savitski MM, Ziegler E, Butzmann L, Gessulat S, Marx H, Mathieson T, Lemeer S, Schnatbaum K, Reimer U, Wenschuh H, Mollenhauer M, Slotta-Huspenina J, Boese JH, Bantscheff M, Gerstmair A, Faerber F, Kuster B.

Nature. 2014 May 29;509(7502):582-7. doi: 10.1038/nature13319.

PMID:
24870543
8.

Peptide microarrays enable rapid mimotope optimization for pharmacokinetic analysis of the novel therapeutic antibody IMAB362.

Schnatbaum K, Schmoldt HU, Daneschdar M, Plum LM, Jansong J, Zerweck J, Kühne Y, Masch A, Wenschuh H, Fiedler M, Türeci Ö, Sahin U, Reimer U.

Biotechnol J. 2014 Apr;9(4):545-54. doi: 10.1002/biot.201300456. Epub 2014 Mar 7.

PMID:
24497417
9.

Binding characteristics of [3H]-JSM10292: a new cell membrane-permeant non-peptide bradykinin B2 receptor antagonist.

Faussner A, Schüssler S, Feierler J, Bermudez M, Pfeifer J, Schnatbaum K, Tradler T, Jochum M, Wolber G, Gibson C.

Br J Pharmacol. 2012 Oct;167(4):839-53. doi: 10.1111/j.1476-5381.2012.02054.x.

10.

Novel small molecule bradykinin B1 receptor antagonists. Part 3: hydroxyurea derivatives.

Schnatbaum K, Schaudt M, Stragies R, Pfeifer JR, Gibson C, Locardi E, Scharn D, Richter U, Kalkhof H, Dinkel K, Zischinsky G.

Bioorg Med Chem Lett. 2010 Feb 1;20(3):1233-6. doi: 10.1016/j.bmcl.2009.11.121. Epub 2009 Dec 2.

PMID:
20036120
11.

Novel small molecule bradykinin B1 receptor antagonists. Part 2: 5-membered diaminoheterocycles.

Zischinsky G, Stragies R, Schaudt M, Pfeifer JR, Gibson C, Locardi E, Scharn D, Richter U, Kalkhof H, Dinkel K, Schnatbaum K.

Bioorg Med Chem Lett. 2010 Feb 1;20(3):1229-32. doi: 10.1016/j.bmcl.2009.11.120. Epub 2009 Dec 2.

PMID:
20015651
12.

Novel small molecule bradykinin B1 receptor antagonists. Part 1: benzamides and semicarbazides.

Schaudt M, Locardi E, Zischinsky G, Stragies R, Pfeifer JR, Gibson C, Scharn D, Richter U, Kalkhof H, Dinkel K, Schnatbaum K.

Bioorg Med Chem Lett. 2010 Feb 1;20(3):1225-8. doi: 10.1016/j.bmcl.2009.11.119. Epub 2009 Dec 2.

PMID:
20015645
13.

Novel small molecule bradykinin B2 receptor antagonists.

Gibson C, Schnatbaum K, Pfeifer JR, Locardi E, Paschke M, Reimer U, Richter U, Scharn D, Faussner A, Tradler T.

J Med Chem. 2009 Jul 23;52(14):4370-9. doi: 10.1021/jm9002445.

PMID:
19552431
14.

Complement 5a receptor inhibition improves renal allograft survival.

Gueler F, Rong S, Gwinner W, Mengel M, Bröcker V, Schön S, Greten TF, Hawlisch H, Polakowski T, Schnatbaum K, Menne J, Haller H, Shushakova N.

J Am Soc Nephrol. 2008 Dec;19(12):2302-12. doi: 10.1681/ASN.2007111267. Epub 2008 Aug 27.

15.

Peptidomimetic C5a receptor antagonists with hydrophobic substitutions at the C-terminus: increased receptor specificity and in vivo activity.

Schnatbaum K, Locardi E, Scharn D, Richter U, Hawlisch H, Knolle J, Polakowski T.

Bioorg Med Chem Lett. 2006 Oct 1;16(19):5088-92. Epub 2006 Jul 28.

PMID:
16876401

Supplemental Content

Loading ...
Support Center